A University of New England researcher recently received a seed grant from the national Tuberous Sclerosis Association to expand research on tuberous sclerosis complex (TSC), a genetic disease characterized by the development of tumors across multiple organs.
The funding will enable Harry Filippakis, Ph.D., an assistant professor in the UNE College of Medicine (UNE COM) Department of Biomedical Sciences, who specializes in cellular metabolism and disease signaling pathways, to identify new biomarkers for TSC, with the long-term goal of developing sustainable therapeutic options for patients with this rare condition.